Wedbush Securities’s PDS Biotechnology PDSB Stock Holding History

Wedbush Securities’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$20K	–	1000
2020 Q2	$20K	Buy	+10,000	New	+$11.1K	﹤0.01%	943

Other funds holding PDSB

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wedbush Securities's PDSB Position: Q3 2020 in Review

Wedbush Securities sold out of PDS Biotechnology (PDSB) in Q3 2020, closing a stake of 10,000 shares — an estimated $20K sold.

Wedbush Securities first reported a position in PDSB in Q2 2020 and held it in 1 quarter. The position peaked at $20K in Q2 2020. 31 funds tracked by Wall St. Rank hold PDSB as of Q3 2020.

Wedbush Securities reported no remaining PDS Biotechnology position as of Q3 2020 after selling out during the quarter.
Wedbush Securities sold 10,000 PDS Biotechnology shares in Q3 2020, an estimated $20K.
Wedbush Securities first reported a position in PDS Biotechnology in Q2 2020 and held it in 1 quarter.
Wedbush Securities's PDS Biotechnology position peaked at $20K in Q2 2020.
31 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2020.

Based on Wedbush Securities's 13F filing for Q3 2020, filed 20 Oct 2020.